Showing results (361-370 of 569) with videos related to

Sort By:
Pageof 57
Therapeutic Drug Monitoring|January 1, 1986
Pharmacokinetic comparison of cisplatin in solution with common lyophilized cisplatinum (Platinol)J B Vermorken, W J van der Vijgh, I Klein, et al.
British Journal of Cancer|March 1, 1988
In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracilG J Peters, J van Dijk, E Laurensse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profileN Feller, K Hoekman, C M Kuiper, et al.
International Journal of Cancer|July 30, 1992
The effect of schedule, protein binding and growth factors on the activity of suraminR Lopez Lopez, G J Peters, A C van Loenen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1984
Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5J P Neijt, W W ten Bokkel Huinink, M E van der Burg, et al.
British Journal of Cancer|September 20, 2000
Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell linesJ R Kroep, G Giaccone, C Tolis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Gemcitabine-cisplatin: a schedule finding studyJ R Kroep, G J Peters, C J van Moorsel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Doxorubicin gradients in human breast cancerJ Lankelma, H Dekker, F R Luque, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1986
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials groupU Bruntsch, P Dodion, W W Ten Bokkel Huinink, et al.
Investigational New Drugs|January 1, 1983
Pharmacokinetics of 4'-epi-doxorubicin in manH Weenen, J Lankelma, P G Penders, et al.
Pageof 57